UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia

Molecular psychiatry, 2022-04, Vol.27 (4), p.1866-1868

2022

Volltextzugriff (PDF)

A neuroimaging biomarker for striatal dysfunction in schizophrenia

Nature medicine, 2020-04, Vol.26 (4), p.558-565

2020

Volltextzugriff (PDF)

White matter microstructural differences across major depressive disorder, bipolar disorder and schizophrenia: A tract-based spatial statistics study

Journal of affective disorders, 2020-01, Vol.260, p.281-286

2020

Volltextzugriff (PDF)

Short-term antipsychotic treatment reduces functional connectivity of the striatum in first-episode drug-naïve early-onset schizophrenia

Schizophrenia research, 2024-08, Vol.270, p.281-288

2024

Volltextzugriff (PDF)

Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study

Translational psychiatry, 2021-08, Vol.11 (1), p.422-422, Article 422

2021

Volltextzugriff (PDF)

Serum S100B protein and white matter changes in schizophrenia before and after medication

Brain research bulletin, 2024-05, Vol.210, p.110927-110927, Article 110927

2024

Volltextzugriff (PDF)

Aberrant Dynamic Functional Network Connectivity and Graph Properties in Major Depressive Disorder

Frontiers in psychiatry, 2018-07, Vol.9, p.339-339

2018

Volltextzugriff (PDF)

Genome wide association study identifies four loci for early onset schizophrenia

Translational psychiatry, 2021-04, Vol.11 (1), p.248-248, Article 248

2021

Volltextzugriff (PDF)

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

Translational psychiatry, 2021-11, Vol.11 (1), p.595-595, Article 595

2021

Volltextzugriff (PDF)

Autophagy defects at weaning impair complement-dependent synaptic pruning and induce behavior deficits

Journal of neuroinflammation, 2024-09, Vol.21 (1), p.239-18, Article 239

2024

Volltextzugriff (PDF)

Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site FMRI data

EBioMedicine, 2019-09, Vol.47, p.543-552

2019

Volltextzugriff (PDF)

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

Psychopharmacology, 2014, Vol.231 (2), p.319-325

2014

Volltextzugriff (PDF)

A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression

Molecular psychiatry, 2021-11, Vol.26 (11), p.6896-6911

2021

Volltextzugriff (PDF)

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study

Translational psychiatry, 2022-02, Vol.12 (1), p.56-56, Article 56

2022

Volltextzugriff (PDF)

Neuregulin-1 immunoreactivity in peripheral plasma is associated with rs6982890 polymorphism-mediated psychotic symptoms in schizophrenia

Brain research bulletin, 2024-10, Vol.217, p.111075, Article 111075

2024

Volltextzugriff (PDF)

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight

Schizophrenia research, 2013-10, Vol.150 (1), p.269-273

2013

Volltextzugriff (PDF)

Chronic developmental exposure to low-dose ([C8mim][PF6]) induces neurotoxicity and behavioural abnormalities in rats

Ecotoxicology and environmental safety, 2021-12, Vol.225, p.112806-112806, Article 112806

2021

Volltextzugriff (PDF)

Activation of Th17 cells in drug naïve, first episode schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 2014-06, Vol.51, p.78-82

2014

Volltextzugriff (PDF)

Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia

BMC medicine, 2021-08, Vol.19 (1), p.177-15, Article 177

2021

Volltextzugriff (PDF)

Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2019-08, Vol.44 (9), p.1552-1561

2019

Volltextzugriff (PDF)

Identification of a functional human-unique 351-bp Alu insertion polymorphism associated with major depressive disorder in the 1p31.1 GWAS risk loci

Neuropsychopharmacology (New York, N.Y.), 2020-06, Vol.45 (7), p.1196-1206

2020

Volltextzugriff (PDF)

Crosstalk of Synapsin1 palmitoylation and phosphorylation controls the dynamicity of synaptic vesicles in neurons

Cell death & disease, 2022-09, Vol.13 (9), p.786-786, Article 786

2022

Volltextzugriff (PDF)

A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: A randomized controlled trial

Journal of psychiatric research, 2020-07, Vol.126, p.81-91

2020

Volltextzugriff (PDF)

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine

Frontiers in psychiatry, 2021-12, Vol.12, p.782289-782289

2021

Volltextzugriff (PDF)

Transcriptome-Wide Association Study Provides Insights Into the Genetic Component of Gene Expression in Anxiety

Frontiers in genetics, 2021-09, Vol.12, p.740134-740134

2021

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(171)
Tagungsberichte
(3)

Sprache

Englisch
(173)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(140)
Schizophrenia
(107)
Humans
(99)
Psychiatry
(93)
Female
(69)
Male
(67)
Adult
(59)
Neurosciences
(58)
Neurosciences & Neurology
(56)
Mental Disorders
(35)
Schizophrenia - Drug Therapy
(35)
Young Adult
(35)
Schizophrenia - Genetics
(33)
Antipsychotic Agents - Therapeutic Use
(26)
Behavioral Sciences
(25)
Magnetic Resonance Imaging
(24)
Adolescent
(23)
Genomes
(23)
Polymorphism, Single Nucleotide
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia

A neuroimaging biomarker for striatal dysfunction in schizophrenia

White matter microstructural differences across major depressive disorder, bipolar disorder and schizophrenia: A tract-based spatial statistics study

Short-term antipsychotic treatment reduces functional connectivity of the striatum in first-episode drug-naïve early-onset schizophrenia

Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study

Serum S100B protein and white matter changes in schizophrenia before and after medication

Aberrant Dynamic Functional Network Connectivity and Graph Properties in Major Depressive Disorder

Genome wide association study identifies four loci for early onset schizophrenia

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

Autophagy defects at weaning impair complement-dependent synaptic pruning and induce behavior deficits

Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site FMRI data

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study

Neuregulin-1 immunoreactivity in peripheral plasma is associated with rs6982890 polymorphism-mediated psychotic symptoms in schizophrenia

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight

Chronic developmental exposure to low-dose ([C8mim][PF6]) induces neurotoxicity and behavioural abnormalities in rats

Activation of Th17 cells in drug naïve, first episode schizophrenia

Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia

Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder

Identification of a functional human-unique 351-bp Alu insertion polymorphism associated with major depressive disorder in the 1p31.1 GWAS risk loci

Crosstalk of Synapsin1 palmitoylation and phosphorylation controls the dynamicity of synaptic vesicles in neurons

A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: A randomized controlled trial

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine

Transcriptome-Wide Association Study Provides Insights Into the Genetic Component of Gene Expression in Anxiety

Suchergebnisse filtern